Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Radiotherapy, Intensity-Modulated × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 23 Oropharyngeal Neoplasms 18 Prostatic Neoplasms 11 Nasopharyngeal Carcinoma 11 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Laryngeal Neoplasms 8 Head and Neck Neoplasms 8 Mouth Neoplasms 7 Carcinoma, Squamous Cell 7 Carcinoma 7 Hypopharyngeal Neoplasms 6 Glioblastoma 6 Breast Neoplasms 6 Uterine Cervical Neoplasms 5 Glioma 5 Esophageal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Papillomavirus Infections 4 Lung Neoplasms 4 Astrocytoma 4 Neoplasm Metastasis 3 Nasopharyngeal Neoplasms 3 Lymphatic Metastasis 3 Leukemia, Myeloid, Acute 3 Endometrial Neoplasms 3 Anus Neoplasms 3 Tumor Virus Infections 2 Thyroid Carcinoma, Anaplastic 2 Sarcoma 2

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡